B. Dubray

发表

A qualitative and a quantitative analysis of an auto-segmentation module for prostate cancer.

P. Kunz, D. Huyskens, P. Maingon, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prevalence of burnout, depression and job satisfaction among French senior and resident radiation oncologists.

B. Dubray, I. Lazarescu, M. Joulakian, 2018, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial.

P. Maingon, B. Dubray, N. Salem, 2011, International journal of radiation oncology, biology, physics.

Nomograms to predict late urinary toxicity after prostate cancer radiotherapy.

T. Messai, B. Dubray, O. Acosta, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Random forests to predict rectal toxicity following prostate cancer radiation therapy.

J. C. Correa, B. Dubray, O. Acosta, 2014, International journal of radiation oncology, biology, physics.

[Respiration-gated radiotherapy: current techniques and potential benefits].

P. Giraud, B. Dubray, J. Cosset, 2003, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing.

J C Rosenwald, P Giraud, B Dubray, 2001, International journal of radiation oncology, biology, physics.

Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists.

Bernard Dubray, Vincent Servois, Philippe Giraud, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Analysing the effects of anaemia on local recurrence of head and neck cancer when covariate values are missing.

N Schenker, J M Taylor, B Dubray, 2000, Statistics in medicine.

High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer

R. Modzelewski, B. Dubray, I. Gardin, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25.

V. Servois, B. Dubray, A. Denys, 1994, Radiology.

Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS)

S. Culine, B. Dubray, B. Asselain, 2021, BMC cancer.

Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study.

P. Giraud, B. Dubray, J. Cosset, 1996, Radiology.

Hypoxia Imaging and Adaptive Radiotherapy: A State-of-the-Art Approach in the Management of Glioma

B. Dubray, M. Bernaudin, S. Valable, 2019, Front. Med..

Histopathological and cellular studies of a case of cutaneous radiation syndrome after accidental chronic exposure to a cesium source.

B. Dubray, M. Martin, J. Lefaix, 1999, Radiation research.

FDG-PET imaging for radiotherapy target volume definition in lung cancer

R. Modzelewski, B. Dubray, S. Ruan, 2014 .

Audit of effectiveness of routine follow-up clinics after radiotherapy for cancer: a report of the REACT working group of ESTRO.

C. Haie-meder, M. Marcenaro, V. Vitale, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prognostic value of post-induction chemotherapy 18F-FDG PET-CT in stage II/III non-small cell lung cancer before (chemo-) radiation

B. Dubray, S. Thureau, P. Vera, 2019, PloS one.

Evaluation of a Dedicated Software “Elements™ Spine SRS, Brainlab®” for Target Volume Definition in the Treatment of Spinal Bone Metastases With Stereotactic Body Radiotherapy

B. Dubray, S. Thureau, A. H. Henni, 2022, Frontiers in Oncology.

(FLT), and hypoxia with 18 fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): A pilot study

L. Thiberville, R. Modzelewski, B. Dubray, 2011 .

Altered proliferation and differentiation of human epidermis in cases of skin fibrosis after radiotherapy.

B. Dubray, J. Lefaix, J. Cosset, 2002, International journal of radiation oncology, biology, physics.

FDG-PET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy doses

B. Dubray, K. Doyeux, I. Gardin, 2015, Acta oncologica.

In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin's lymphomas.

J. Klijanienko, B. Dubray, H. Magdelenat, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer

R. Modzelewski, B. Dubray, S. Thureau, 2020, Radiation oncology.

Comparative analysis of apoptosis measured by Hoechst and flow cytometry in non-Hodgkin's lymphomas.

J. Klijanienko, B. Dubray, H. Magdelenat, 1998, Cytometry.

Concomitant chemoradiotherapy followed, where feasible, by surgery for cancer of the esophagus.

B. Dubray, J. Douillard, P. Martin, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Early and late injuries in mouse rectum after fractionated X-ray and neutron irradiation.

J. Fowler, B. Dubray, H. Thames, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study.

B. Dubray, B. Asselain, J. Cosset, 1995, International journal of radiation oncology, biology, physics.

Chronic radiation damage in the rat rectum: an analysis of the influences of fractionation, time and volume.

B. Dubray, H. Thames, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Clinical target volume delineation for radiotherapy of the esophagus].

B. Dubray, I. Lazarescu, S. Thureau, 2013, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Is reseeding from the primary a plausible cause of node failure?

B. Dubray, B. Asselain, H. Thames, 1993, International journal of radiation oncology, biology, physics.

The influence of dose and time on the cure of larynx tumors.

B. Dubray, H. Thames, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Diagnosis of abdominal venous thrombosis by means of spin-echo and gradient-echo MR imaging: analysis with receiver operating characteristic curves.

V. Vilgrain, B. Dubray, M. Vullierme, 1991, Radiology.

In vivo induction of apoptosis in human lymphocytes by therapeutic fractionated total body irradiation.

B. Dubray, H. Magdelenat, J. Cosset, 1995, The British journal of radiology.

Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival.

B. Fertil, B. Dubray, R. Lubin, 1993, International journal of radiation oncology, biology, physics.

Segmentation of 18F-Miso PET images

Laurent Mouchard, Su Ruan, Benoît Lelandais, 2012 .

Single dose versus fractionated total body irradiation before bone marrow transplantation: radiobiological and clinical considerations.

B. Dubray, J. Cosset, G. Socié, 1994, International journal of radiation oncology, biology, physics.

Fractionation Sensitivity of Mammalian Tissues

B. Dubray, J. Cosset, T. Girinsky, 1994 .

Ionizing radiation effects on the KG1a primitive hematopoietic cell line.

B. Dubray, E. Carosella, G. Socié, 1996, International journal of radiation oncology, biology, physics.

Post-irradiation hyperamylasemia as a biological dosimeter.

B. Dubray, H. Thames, J. Cosset, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Exclusive Hyper-fractionated Radiotherapy and reduced boost volume for standard-risk medulloblastoma: pooled analysis of the two French multicentric studies MSFOP98 and MSFOP 2007 and correlation with molecular subgroups.

B. Dubray, D. Figarella-Branger, P. Bondiau, 2020, International journal of radiation oncology, biology, physics.

Soluble interleukin‐2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma

P. Validire, B. Dubray, E. Tartour, 1997, Cancer.

Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.

N. Magné, B. Dubray, D. Peiffert, 2019, The Lancet. Oncology.

Multidisciplinary Tumor Board Decision Making for Postoperative Radiotherapy in Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort

N. Girard, L. Thiberville, B. Dubray, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation.

E. Noordijk, B. Dubray, H. Thames, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.

B. Dubray, S. Guérif, A. Ruffion, 2016, The Lancet. Oncology.

Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer

D. Visvikis, L. de Geus-Oei, W. V. van Elmpt, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Male breast carcinoma: a single centre report of clinical parameters.

B. Dubray, S. Dische, E. Lartigau, 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).

[White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique].

I. Barillot, J. Ferlay, C. de Martel, 2013, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Segmentation of pelvic organs at risk using superpixels and graph diffusion in prostate radiotherapy

Su Ruan, Maxime Guinin, Lamyaa Nkhali, 2015, 2015 IEEE 12th International Symposium on Biomedical Imaging (ISBI).

[Diagnosis and treatment of soft-tissue tumors].

B. Dubray, M. Debled, P. Vera, 2006, Revue de chirurgie orthopedique et reparatrice de l'appareil moteur.

[Changes of the cutaneous micro-relief in superficial radiation-induced fibrosis: a qualitative study].

P. Giraud, B. Dubray, J. Lefaix, 1996, Bulletin du cancer.

Robust feature selection to predict tumor treatment outcome

Su Ruan, Caroline Petitjean, Pierre Vera, 2014, Artif. Intell. Medicine.

Oral Vinorelbine and Cisplatin as Induction Chemotherapy and Concomitant Chemo-Radiotherapy in Stage III Non-small Cell Lung Cancer: Final Results of an International Phase II Trial

A. Kuten, M. Krzakowski, B. Dubray, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC

R. Modzelewski, B. Dubray, S. Thureau, 2021, Scientific Reports.

Comparison of Hypermetabolic and Hypoxic Volumes Delineated on [18F]FDG and [18F]Fluoromisonidazole PET/CT in Non-small-cell Lung Cancer Patients

R. Modzelewski, B. Dubray, S. Hapdey, 2019, Molecular Imaging and Biology.

Radiotherapy boost in patients with hypoxic lesions identified by 18F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up]

R. Modzelewski, B. Dubray, P. Chaumet‐Riffaud, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer

R. Modzelewski, B. Dubray, S. Hapdey, 2018, Radiation Oncology.

Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non–Small Cell Lung Carcinoma (RTEP5 Study)

Maximilien Vermandel, Pierre Vera, Bernard Dubray, 2017, The Journal of Nuclear Medicine.

Areas of High 18F-FDG Uptake on Preradiotherapy PET/CT Identify Preferential Sites of Local Relapse After Chemoradiotherapy for Non–Small Cell Lung Cancer

L. Thiberville, R. Modzelewski, B. Dubray, 2015, The Journal of Nuclear Medicine.

Can modest escalations of dose be detected as increased tumor control?

T E Schultheiss, W A Brock, J H Hendry, 1992, International journal of radiation oncology, biology, physics.

HDR versus LDR gynecological brachytherapy revisited.

A. Gerbaulet, B. Dubray, P. Scalliet, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prospective study of the clinical symptoms of therapeutic whole body irradiation.

B. Dubray, J. Cosset, G. Socié, 1993, Health physics.

Interobserver Agreement of Qualitative Analysis and Tumor Delineation of 18F-Fluoromisonidazole and 3′-Deoxy-3′-18F-Fluorothymidine PET Images in Lung Cancer

R. Modzelewski, B. Dubray, P. Fernandez, 2013, The Journal of Nuclear Medicine.

Delineation of small mobile tumours with FDG-PET/CT in comparison to pathology in breast cancer patients.

Pierre Vera, Bernard Dubray, Isabelle Gardin, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0

D. Visvikis, L. de Geus-Oei, W. V. van Elmpt, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2)

Pierre Vera, Bernard Dubray, Pierre Olivier, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Time factors in breast carcinoma: influence of delay between external irradiation and brachytherapy.

B. Dubray, H. Thames, C. Le Péchoux, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).

Pierre Vera, Bernard Dubray, Isabelle Gardin, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot

Luc Thiberville, Pierre Vera, Bernard Dubray, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Does short-term androgen depletion add to high-dose radiotherapy (80 Gy) in localized intermediate-risk prostate cancer? Intermediary analysis of GETUG 14 randomized trial (EU-20503/NCT00104741).

B. Dubray, J. Bachaud, S. Guérif, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Focal HIFU for prostate cancer.

B. Dubray, J. Kaanders, B. Jereczek-Fossa, 2012, The Lancet. Oncology.

Interest of short hormonotherapy (HT) associated with radiotherapy (RT) as salvage treatment for metastatic free survival (MFS) after radical prostatectomy (RP): Update at 9 years of the GETUG-AFU 16 phase III randomized trial (NCT00423475).

N. Magné, B. Dubray, D. Peiffert, 2019, Journal of Clinical Oncology.

Nomograms to predict late urinary toxicity after prostate cancer radiotherapy

R. Crevoisier, B. Dubray, O. Acosta, 2013, World Journal of Urology.

The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity.

P. Maingon, B. Dubray, N. Salem, 2004, International journal of radiation oncology, biology, physics.

Multiorgan segmentation using distance-aware adversarial networks

Su Ruan, Roger Trullo, Caroline Petitjean, 2019, Journal of medical imaging.

Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal window.

J. Picquenot, R. Modzelewski, B. Dubray, 2015, Nuclear medicine and biology.

Evaluation of a rigid registration method of lung perfusion SPECT and thoracic CT.

Bernard Dubray, Isabelle Gardin, B. Dubray, 2005, AJR. American journal of roentgenology.

Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma

Pierre Michel, Pierre Vera, Bernard Dubray, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancer

Irène Buvat, Pierre Michel, Pierre Vera, 2014, EJNMMI Research.

Reproducibility of measurements of potential doubling time of tumour cells in the multicentre National Cancer Institute protocol T92-0045

B. Dubray, P. Coucke, G. Wilson, 1999, British Journal of Cancer.

FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer

R. Modzelewski, B. Dubray, S. Hapdey, 2018, Radiation oncology.

HDR Versus LDR Gynecological Brachytherapy Revisited

A. Gerbaulet, B. Dubray, P. Scalliet, 1994 .

Prediction of Lung Tumor Evolution During Radiotherapy in Individual Patients With PET

Su Ruan, Caroline Petitjean, Pierre Vera, 2014, IEEE Transactions on Medical Imaging.

The clinical significance of ratios of radiobiological parameters.

H D Thames, B. Dubray, H. Thames, 1996, International journal of radiation oncology, biology, physics.

In vitro radiation-induced apoptosis and tumour response to radiotherapy: a prospective study in patients with non-Hodgkin lymphomas treated by low-dose irradiation.

J. Klijanienko, B. Dubray, H. Magdelenat, 1997, International journal of radiation biology.

Influence of total treatment time on local control rates after radiotherapy for breast cancer

B. Dubray, H. Thames, E. Schueren, 1991 .

Combined Modality Treatment for Poor Prognosis Stages I and II Hodgkin's Disease.

E. Noordijk, B. Dubray, J. Cosset, 1996, Seminars in radiation oncology.

Segmentation of Organs at Risk in thoracic CT images using a SharpMask architecture and Conditional Random Fields

Dinggang Shen, Su Ruan, Caroline Petitjean, 2017, 2017 IEEE 14th International Symposium on Biomedical Imaging (ISBI 2017).

[Esophageal toxicity of radiation therapy: clinical risk factors and management].

P. Giraud, B. Dubray, S. Thureau, 2012, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Delegation of medical tasks in French radiation oncology departments: current situation and impact on residents' training.

J. Bibault, P. Giraud, B. Dubray, 2013, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Late effects of radiation on normal tissues].

B. Dubray, J. Cosset, L. Chauveinc, 1994, La Revue du praticien.

Estimation of clonogenic cell fraction in primary cultures derived from human squamous cell carcinomas.

B. Dubray, N. Chavaudra, W. Brock, 1991, International journal of radiation oncology, biology, physics.

Radiobiological and Clinical Bases for Total Body Irradiation in the Leukemias and Lymphomas.

B. Dubray, J. Cosset, G. Socié, 1995, Seminars in radiation oncology.

Clinical Efficacy of Irradiation in CLL Patients: Predictive Value of in Vitro Radio-induced Apoptosis

B. Dubray, E. Blot, J. Cosset, 2002, Leukemia & lymphoma.

SegTHOR: Segmentation of Thoracic Organs at Risk in CT images

Z. Lambert, C. Petitjean, B. Dubray, 2019, 2020 Tenth International Conference on Image Processing Theory, Tools and Applications (IPTA).

[Late effects of mammary radiotherapy on skin and subcutaneous tissues].

B. Dubray, J. Lefaix, S. Delanian, 1997, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Interest of FDG-PET for lung cancer radiotherapy].

R. Modzelewski, B. Dubray, S. Thureau, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Soluble interleukin‐2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma

P. Validire, B. Dubray, E. Tartour, 1997, Cancer.

[Clinical value of the potential doubling time (Tpot) measured by flow cytometry].

B. Dubray, J. Cosset, N. Terry, 1995, Bulletin du cancer.

[Alpha/beta ratio revisited in the era of hypofractionation].

B. Dubray, C. Hennequin, 2013, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.